| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.42▲ | 5.49▼ | 5.50▼ | 5.53▼ | 5.14▲ |
| MA10 | 5.43▲ | 5.52▼ | 5.55▼ | 5.28▲ | 4.99▲ |
| MA20 | 5.47▼ | 5.56▼ | 5.61▼ | 5.17▲ | 5.82▼ |
| MA50 | 5.52▼ | 5.60▼ | 5.37▲ | 5.21▲ | 4.62▲ |
| MA100 | 5.56▼ | 5.34▲ | 5.21▲ | 5.84▼ | 3.18▲ |
| MA200 | 5.61▼ | 5.20▲ | 5.07▲ | 5.23▲ | 5.24▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.017▼ | -0.040▼ | 0.076▲ | -0.151▼ |
| RSI | 40.903▼ | 34.214▼ | 43.746▼ | 55.398▲ | 50.783▲ |
| STOCH | 18.671▼ | 25.458 | 23.476 | 73.263 | 31.896 |
| WILL %R | -61.538 | -82.143▼ | -86.111▼ | -37.374 | -68.243 |
| CCI | -67.185 | -195.736▼ | -193.062▼ | 94.889 | 7.276 |
|
Monday, March 09, 2026 03:15 PM
Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage initiations and maintained Buy-equivalent ratings from institutional research desks ahead of 2026 ...
|
|
Friday, March 06, 2026 04:32 PM
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that ...
|
|
Friday, March 06, 2026 05:01 AM
Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients, well above the standard of care benchmark from GnP of 35% overall survival; On track for expanded pancreatic cancer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/03/26 | 5.66 | 5.70 | 5.39 | 5.45 | 595,115 |
| 11/03/26 | 5.53 | 5.77 | 5.52 | 5.65 | 521,259 |
| 10/03/26 | 5.64 | 5.82 | 5.61 | 5.62 | 593,976 |
| 09/03/26 | 5.22 | 5.67 | 5.165 | 5.62 | 1,037,328 |
| 06/03/26 | 4.85 | 5.39 | 4.83 | 5.33 | 969,700 |
| 05/03/26 | 5.10 | 5.12 | 4.88 | 4.98 | 943,019 |
| 04/03/26 | 4.98 | 5.19 | 4.92 | 5.17 | 710,783 |
| 03/03/26 | 4.88 | 5.21 | 4.87 | 4.95 | 1,028,701 |
| 02/03/26 | 4.85 | 5.10 | 4.8363 | 5.00 | 777,071 |
| 27/02/26 | 4.95 | 5.10 | 4.94 | 4.99 | 812,927 |
|
|
||||
|
|
||||
|
|